» Articles » PMID: 21922348

Venous Access Ports: Indications, Implantation Technique, Follow-up, and Complications

Overview
Date 2011 Sep 17
PMID 21922348
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

The subcutaneous venous access device (SVAD or "port") is a critical component in the care of patients with chronic disease. The modern SVAD provides reliable access for blood withdrawal and medication administration with minimal disruption to a patient's lifestyle. Because of improved materials and catheter technology, today's ports are lighter and stronger and capable of high-pressure injections of contrast for cross-sectional imaging. The majority of SVAD placement occurs in interventional radiology departments due to their ability to provide this service at lower costs, lower, complication rates, and greater volumes. Port-insertion techniques vary depending on the operator, but all consist of catheter placement in the central venous circulation followed by subcutaneous pocket creation and port attachment to the catheter with fixation and closure of the pocket. Venous access challenges occasionally occur in patients with central vein occlusions, necessitating catheterization of collateral veins or port placement in alternate locations. Complications of SVADs include those associated with the procedure as well as short- (<30 days) and long-term problems. Procedural and early complications are quite rare due to the near-universal use of real-time ultrasound guidance for vein puncture, but they can include hematoma, catheter malposition, arrhythmias, and pneumothorax. Late problems include both thrombotic complications (native venous or port-catheter thrombosis) and infections (tunnel or pocket infections or catheter-associated bloodstream infections). Most guidelines suggest that 0.3 infections/1000 catheter days is an appropriate upper threshold for the insertion of SVADs.

Citing Articles

Evaluating the Characteristics of the Totally Implantable Venous Access Device in Cancer Patients Using Fluorodeoxyglucose-PET/CT in the Absence of Suspected Catheter-Related Infections.

Kato K, Makoto H, Suzuki T, Yoshioka K Cureus. 2025; 17(2):e78621.

PMID: 40062140 PMC: 11890020. DOI: 10.7759/cureus.78621.


Iatrogenic Superior Vena Cava Syndrome With Extensive Thromboembolism Associated With Chronic Indwelling Catheterization.

Song X, Whittles J, Ding X Cureus. 2025; 17(1):e78179.

PMID: 40026999 PMC: 11870787. DOI: 10.7759/cureus.78179.


Experience with the implementation of central venous catheters by medical oncologists in a non-surgical setting.

Revuelta A, Mihic L, Castillo A, Marino A, Mateos L, Iglesias C Sci Rep. 2025; 15(1):3512.

PMID: 39875398 PMC: 11775252. DOI: 10.1038/s41598-025-86393-1.


An autonomous implantable device for the prevention of death from opioid overdose.

Ciatti J, Vazquez-Guardado A, Brings V, Park J, Ruyle B, Ober R Sci Adv. 2024; 10(43):eadr3567.

PMID: 39441938 PMC: 11498215. DOI: 10.1126/sciadv.adr3567.


Evaluation of a novel central venous access port for direct catheter insertion without a peel-away sheath.

Iguchi T, Kawabata T, Matsui Y, Tomita K, Uka M, Umakoshi N Jpn J Radiol. 2024; 43(2):282-289.

PMID: 39287917 PMC: 11790760. DOI: 10.1007/s11604-024-01658-5.